Johnson & Johnson: Dividend King for 60 Years – Is the Stock Still a Buy?
Johnson & Johnson (JNJ) continues to raise its dividend for over 60 consecutive years, making it a reliable income stock. However, the harder question is whether the current share price offers good value.
Key Numbers
According to a report from Motley Fool, Johnson & Johnson (JNJ) has achieved a rare feat: increasing its dividend annually for more than 60 consecutive years. This places it among the elite group of "Dividend Kings." However, the report highlights that the bigger challenge for investors now is the stock's valuation, not the sustainability of the dividend.
Dividend Sustainability
JNJ benefits from strong cash flows and a diversified portfolio (pharmaceuticals, medical devices, consumer products), supporting its ability to continue raising dividends. The payout ratio remains at comfortable levels.
Stock Valuation
The critical question: Is the current stock price attractive? With the stock trading at a P/E ratio above its historical average, some analysts consider it somewhat expensive. Additionally, legal risks related to talc lawsuits could weigh on performance.
What This Means for Investors
For income-focused investors seeking stable dividends, JNJ remains a solid choice. However, growth-oriented investors may find better opportunities elsewhere. The decision depends on each investor's goals and time horizon.
Frequently Asked Questions
Found this useful? Share it